Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BARBARA A LUBIN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1629007885
CMS profile
299998
Location
PANAMA CITY, FL

General Payments · PY2018–2024

$1,943.13

  • Reported across 101 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$245.61

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $245.61 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $139.10 9
Exact Sciences Corporation $66.61 4
IBSA Pharma Inc. $39.90 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $584.83 28
PY2019 $182.54 11
PY2020 $290.71 15
PY2021 $121.02 7
PY2022 $229.92 7
PY2023 $288.50 18
PY2024 $245.61 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Exact Sciences Corporation $15.00 02/19/2024 Food and Beverage Undisputed 01/23/2026 1114764279 CMS
Exact Sciences Corporation $15.37 05/07/2024 Food and Beverage Undisputed 01/23/2026 1114764284 CMS
Exact Sciences Corporation $17.68 07/18/2024 Food and Beverage Undisputed 01/23/2026 1114764290 CMS
Exact Sciences Corporation $18.56 10/09/2024 Food and Beverage Undisputed 01/23/2026 1114764296 CMS
IBSA Pharma Inc. $20.57 08/01/2024 Food and Beverage Undisputed 01/23/2026 1142972925 CMS
IBSA Pharma Inc. $19.33 11/19/2024 Food and Beverage Undisputed 01/23/2026 1142975835 CMS
Novo Nordisk Inc $21.96 01/10/2024 Food and Beverage Undisputed 01/23/2026 1097015995 CMS
Novo Nordisk Inc $20.60 04/24/2024 Food and Beverage Undisputed 01/23/2026 1096982319 CMS
Novo Nordisk Inc $20.98 05/01/2024 Food and Beverage Undisputed 01/23/2026 1097575439 CMS
Novo Nordisk Inc $0.43 07/11/2024 Food and Beverage Undisputed 01/23/2026 1096962199 CMS
Novo Nordisk Inc $7.09 07/11/2024 Food and Beverage Undisputed 01/23/2026 1097669352 CMS
Novo Nordisk Inc $20.82 07/29/2024 Food and Beverage Undisputed 01/23/2026 1097748767 CMS
Novo Nordisk Inc $7.41 08/08/2024 Food and Beverage Undisputed 01/23/2026 1096904365 CMS
Novo Nordisk Inc $15.17 08/28/2024 Food and Beverage Undisputed 01/23/2026 1096994594 CMS
Novo Nordisk Inc $24.64 10/23/2024 Food and Beverage Undisputed 01/23/2026 1096749370 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.